Anebulo Pharmaceuticals Stock Pattern Recognition Separating Lines
| ANEB Stock | USD 0.48 0.01 2.13% |
| Symbol |
Recognition |
The output start index for this execution was eleven with a total number of output elements of fifty. The function generated a total of two valid pattern recognition events for the selected time horizon. The Separating Lines pattern occurs when there is an uptrend in Anebulo Pharmaceuticals movement followed by an immediate pullback.
Anebulo Pharmaceuticals Technical Analysis Modules
Most technical analysis of Anebulo Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Anebulo from various momentum indicators to cycle indicators. When you analyze Anebulo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. The company was incorporated in 2020 and is based in Lakeway, Texas. Anebulo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. The profile for Anebulo Pharmaceuticals integrates fundamentals, price behavior, and sector exposure. Defensive traits reduce macro sensitivity. Anebulo Pharmaceuticals has a market cap of 18.35 M, ROE of -69.69%. 
Rifka Kats ยท Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Anebulo Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Anebulo (USA Stocks:ANEB) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Anebulo Pharmaceuticals may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Anebulo Stock is Curated By:
Rifka Kats ยท Member of Macroaxis Editorial BoardSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Anebulo Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Anebulo Pharmaceuticals' short interest history, or implied volatility extrapolated from Anebulo Pharmaceuticals options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | FinTech Invested over 20 shares | |
 | Hedge Favorites Invested over 40 shares | |
 | Momentum Invested over 60 shares | |
 | Impulse Invested over 200 shares | |
 | Social Domain Invested few shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Cash Cows Invested few shares | |
More Resources for Anebulo Stock Analysis
A structured review of Anebulo Pharmaceuticals often starts with core financial statements and trend context. Ratios and trend metrics help frame Anebulo Pharmaceuticals' operating context. Key reports that frame Anebulo Pharmaceuticals Stock are listed below:Anebulo Pharmaceuticals has a market cap of 18.35 M, ROE of -69.69%. Use Trending Equities to explore allocation context. This includes a position in Anebulo Pharmaceuticals in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. To learn how to invest in Anebulo Stock, please use our How to Invest in Anebulo Pharmaceuticals guide.Analysis related to Anebulo Pharmaceuticals should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
The market value of Anebulo Pharmaceuticals is measured differently than book value, which reflects Anebulo accounting equity. Anebulo Pharmaceuticals' market capitalization is 18.35 M. A P/B ratio of 2.31 indicates the market values Anebulo Pharmaceuticals above its accounting book value. Enterprise value stands at 9.31 M. Intrinsic value is an analytical estimate of Anebulo Pharmaceuticals' underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
Note that Anebulo Pharmaceuticals' intrinsic value and market price are different measures derived from different inputs. For Anebulo Pharmaceuticals, key inputs include a P/B ratio of 2.31, and ROE of -69.69%. Market price reflects the current exchange level formed by active bids and offers.